NCT05890833View on ClinicalTrials.gov

The Risk of Falls Index for Patients With Neuromuscular Disorders

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 9, 2024

Study Completion Date

September 9, 2024

Conditions
Inclusion Body MyositisMyotonic DystrophyFacioscapulohumeral Muscular DystrophiesMyasthenia GravisThe Falls Efficacy Scale InternationalThe Morse Fall Scale
Interventions
DIAGNOSTIC_TEST

The risk of falls

Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed. Test battery two includes Timed Up and Go test, 10 Meter Walk Test, Six Minute Walk test, The Falls Efficacy Scale International FES-I, The Morse Fall Scale.

Trial Locations (1)

80336

Marko Mijic, München

All Listed Sponsors
lead

LMU Klinikum

OTHER

NCT05890833 - The Risk of Falls Index for Patients With Neuromuscular Disorders | Biotech Hunter | Biotech Hunter